Legend Biotech Reports Fourth Quarter and Full Year 2023 Results and Recent Highlights
SOMERSET, N.J.--(BUSINESS WIRE)--Mar 11, 2024--
Source: eagletribune.com
Page 28 - Human Use News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Human Use. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Human Use Today - Breaking & Trending Today
Travere Therapeutics Submits Supplemental New Drug Application to the U.S. Food and Drug Administration Seeking Full Approval of FILSPARI® (sparsentan) for the Treatment of IgA Nephropathy (IgAN)
Submission is based on 2-year confirmatory results from the Phase 3 PROTECT Study in which FILSPARI demonstrated a significant reduction in proteinuria, preservation of kidney function and a generally...
Source: marketscreener.com
Missed Out on Eli Lilly? 3 Healthcare Stocks With Big Catalysts on the Horizon.
Good news could be in store for all three of these drugmakers.
Source: yahoo.com
Samsung Bioepis Presents Two Abstracts for Its Immunology Portfolio at the 2024 American Academy of Dermatology (AAD) Annual Meeting
Interchangeability study for HADLIMA (adalimumab-bwwd) was conducted in accordance with the FDA’s Guidance for Industry; primary pharmacokinetics (PK) endpoints as well as efficacy, safety and immunogenicity profiles were comparable between switching group and continuous reference product Humira group 52-week results from SB17 Phase 3 study demonstrated long-term efficacy, safety, and immunogenicity of SB17 compared to reference ustekinumab, including switching from ustekinumab to SB17 INCHEON,
Source: yahoo.com
Primodos: MPs say 'covered-up' evidence could reveal 'one of the biggest medical frauds of 20th century'
An expert working group in 2017 found there was insufficient evidence of a causal association between the Primodos hormone pregnancy test and birth defects - but a team of Oxford academics used the same raw data and got opposite results.
Source: sky.com